Chemical and Genomic-based strategies in the discovery of novel drug targets

Year 2021
Code 5584
Main Department FaBiT Dept.
Campus Bologna
Credits 3 CFU
Cost € 100,00
Starting date Jun 21, 2021
Finishing date Jun 25, 2021
Application deadline Jun 16, 2021 (Expired)
Subject area
Sciences and technology
Learning outcomes
In the last decade we have witnessed changes in the design and conduction of research in the biomedical field, resulting from the decoding of the human genome. In particular , it is relevant that the revolution has been focused on the discovery of new drugs and new drug targets thanks to genomics, transcriptomics and proteomics. The selection and validation of new drug targets requires a number of research strategies that have been developed recently. The aim of the School is to spread among young people in education and among those who are already working in this field, how to best use the tools offered by the most advanced research and updated . Experts, leaders in their field, were invited as lecturers. They will explain, through lectures and exercise, the following topics: chemogenomics, drug discovery, genomics; the role of high-throughput assays; the small interfering RNA; reporter gene models in vitro and in vivo; transcription factors as new therapeutic targets; chemiluminescence Integrated systems for analysis. Finally, we will sketch the lines of the future development of these technologies. In order to better facilitate the dialogue between teachers and students, there are two moments in the middle and at the end of the course, in which students will be encouraged to ask teachers questions on the topics that most interested them.
Number of participants
min.8 max.50
Duration
5 days
Language
English
Admission qualifications
- first cycle degree and/or second / single cycle degree obtained under D.M. 270/04 or first cycle degree and/or second / single cycle degree obtained under the laws previously in force (DM 509/99 and Old Regulations) in the following fields or classes: L-2 Biotechnologies, L-13 Biology, L-29 Pharmacy,LM-6 Biology, LM-8 Industrial Biotechnologies, LM-9 Pharmaceutical, Veterinary and Medical biotechnologies, LM-13 Pharmacy and industrial pharmacy, LM-41 Medicine, LM-54 Chemistry;

- first cycle degree and/or second / single cycle degree obtained abroad deemed equivalent to those described in point above by the admission committee, for the purposes of admission to the Master.

- Other degrees are also accepted, provided they are supported by qualified and documented professional experience or additional documented post-graduate training in the subjects covered by the programme.

- Students enrolled in the 4th or 5th years of LM13 and Ph.D. students in biomedical fields.
Academic director
Santi Mario Spampinato
Study plan
  • Genetic and epigenetic pathways in drug discovery: Nuclear receptors as pharmacological targets; SSD BIO/10 - PROF. Maurizio Crestani
  • Intellectual property and biotechnological innovation; SSD IUS/04; prof.Giorgio Spedicato
  • Laboratory Experience - SSD BIO/14; prof.Andrea Bedini
  • Biased agonism at GPCRs as a novel avenue for more effective and safer drugs: the paradigm of opioid receptors - SSD BIO/14 prof.Andrea Bedini

  • Bioinformatics - SSD BIO/16 - Prof. Alberto Maria Martelli
  • PROteolysis TArgeting Chimeras (PROTACs); new horizons in the development of drugs and therapeutic modalities - SSD CHIM/O8 - Prof.Maria Laura Bolognesi
  • Anti-COVID19 Therapeutic Strategies - SSD Med/17 - prof. Stefano Rusconi
  • Integrin-based drug discovery  - SSD BIO/14 - prof.Monica Baiula

Dott. Gabriele Campana

FaBiT

Address

Via Irnerio 48, 40126 - Bologna

Telephone
+39 051 2091852

Contacts

Dott. Gabriele Campana

FaBiT

Address

Via Irnerio 48, 40126 - Bologna

Telephone
+39 051 2091852